KMDA - Kamada Ltd. News

Kamada Signs $50M Plasma Supply Agreement With Biopharma Partner Through Texas Centers, Commercial S

Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceu

REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

Kamada Highlights Results Of An Investigator-initiated Study Of Cytogam, The Company’s Cytomegalovir

Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated

Kamada Announces FDA Approval Of New In-House Rapid Fluorescent Focus Inhibition Test Laboratory

Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

REHOVOT, Israel and HOBOKEN, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE

marketbeat.com

Kamada Q1 Earnings Call Highlights

Kamada NASDAQ: KMDA reiterated its full-year 2026 outlook after reporting first-quarter results that

seekingalpha.com

Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript

Kamada (KMDA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the qua

Kamada Q1 2026 Earnings Call: Complete Transcript

Earnings Scheduled For May 13, 2026

Kamada Affirms FY2026 Sales Guidance of $200.000M-$205.000M vs $201.581M Est

Kamada (NASDAQ:KMDA) affirms FY2026 sales outlook from $200.000 million-$205.000 million to $200.000

Kamada Q1 EPS $0.07 Misses $0.12 Estimate, Sales $45.240M Miss $46.722M Estimate

Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.07 per share which missed the analyst consens

Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Sign

Q1-2026 Revenue of $45.2 Million, up 3% Year-over-Year; Adjusted EBITDA of $11.6 Million, representi

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

Get a deeper insight into the potential performance of Kamada (KMDA) for the quarter ended March 202

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

REHOVOT, Israel and HOBOKEN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

Kamada Secures Israeli Tax Ruling On $0.25 Dividend, Allowing Reduced Withholding For Nasdaq Treaty

Kamada Ltd. (the "Company") (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical compa

Kamada Says FDA Approves Kamada Plasma's Collection Center In San Antonio

San Antonio Center Cleared to Commence Commercial Sales of Normal Source PlasmaState of the Art Faci

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TAS

seekingalpha.com

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript

Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the qua

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

Kamada (KMDA) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estim

Earnings Scheduled For March 11, 2026

Kamada Affirms FY2026 Sales Guidance of $200.000M-$205.000M

Kamada (NASDAQ:KMDA) affirms FY2026 sales outlook from $200.000 million-$205.000 million to $200.000

Kamada Q4 EPS $0.06 Misses $0.08 Estimate, Sales $44.678M Miss $45.422M Estimate

Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.06 per share which missed the analyst consens

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Represen

REHOVOT, Israel, and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TA

Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Ca

REHOVOT, Israel and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

What's Next: Kamada's Earnings Preview

Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Kamada (KMDA), review projections for some o

KMDA vs. ARGX: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably alrea

KMDA or TECH: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KM

Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock?

Kamada (KMDA) witnessed a jump in share price last session on above-average trading volume. The late

defenseworld.net

Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving Average – Here’s Why

Kamada Ltd. (NASDAQ: KMDA - Get Free Report)'s share price crossed above its fifty day moving averag

Earnings Scheduled For November 10, 2025

Earnings Scheduled For August 13, 2025

Earnings Scheduled For May 14, 2025

Earnings Scheduled For March 5, 2025

Earnings Scheduled For November 13, 2024

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 241 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Friday

On Friday, 1043 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Monday